ISSN 1662-4009 (online)

ey0015.6-7 | New treatments | ESPEYB15

6.7 Puberty suppression in transgender children and adolescents

S Mahfouda , JK Moore , A Siafarikas , FD Zepf , A Lin

To read the full abstract: Lancet Diabetes Endocrinol. 2017 Oct;5(10):816-826See comment on 6.8...

ey0017.6-15 | Transgender Medicine: Reviews and Position Statements | ESPEYB17

6.15. Gender-affirming hormones and surgery in transgender children and adolescents

S Mahfouda , JK Moore , A Siafarikas , T Hewitt , U Ganti , A Lin , FD Zepf

To read the full abstract: Lancet Diabetes Endocrinol. 2019, Jun; 7: 484–98. doi: https://www.ncbi.nlm.nih.gov/pubmed/30528161This review overviews the published literature on mental and physical health outcomes and treatment effects after gender-affirming hormone therapy and surgery in transgender adolescents and highlights important evidence gaps.There is tr...

ey0021.6-12 | Gender Incongruence - Hormone Treatment Continuation | ESPEYB21

6.12. Reidentification with birth-registered sex in a Western Australian pediatric gender clinic cohort

BS Cavve , X Bickendorf , J Ball , LA Saunders , CS Thomas , P Strauss , G Chaplyn , L Marion , A Siafarikas , U Ganti , A Wiggins , A Lin , JK Moore

Brief Summary: This retrospective cohort study investigated referral closures due to reidentification with birth-registered sex at the Child and Adolescent Health Service Gender Diversity Service in Perth, the sole provider of gender-affirming medical treatment for individuals <18 years in Western Australia. Out of 548 referral closures, 29 reidentified with birth-registered sex. Only 2 did so after having started medical treatment, constituting 1.2% (95% CI, 0.1%-4.4%) of...